Why It Matters

The American Academy of Pediatrics (AAP) is escalating its advocacy efforts on Capitol Hill as Congress grapples with the fallout from sweeping healthcare cuts. The One Big Beautiful Bill Act, signed into law last July, narrowed Medicaid eligibility and eliminated coverage for 27,000 children and pregnant women. The Congressional Budget Office projects the law's Medicaid provisions would increase the number of uninsured individuals by 9.1 million by 2034. Meanwhile, a federal court blocked efforts to upend U.S. vaccine policy, but the advocacy landscape remains contested.

By the Numbers

The AAP filed a quarter two 2026 lobbying report disclosing $789,257 in in-house lobbying spending, marking a significant jump from $320,000 in quarter one 2026.

Broader Context

The AAP's lobbying activity addresses several areas of pediatric concern. Food allergies impact an estimated 33 million people in the United States, including 5.6 million children, with approximately 200,000 individuals requiring emergency medical treatment annually due to allergic reactions. The Learning Early about Peanut Allergy trial demonstrated a reduction in peanut allergy development by over 80% in children exposed to peanut-containing foods starting at age 4-10 months.

Congresswoman Doris Matsui and Congressman Mike Gallagher led a group of 10 lawmakers in urging the Dietary Guidelines Advisory Committee to evaluate early introduction of food allergens. The organization also faces fallout from terminated federal grants that had supported programs to prevent sudden unexpected infant death, improve early detection of developmental disabilities, strengthen pediatric care in rural communities, support adolescents facing substance use and mental health challenges, and improve standards of care for newborns.

The Bottom Line

The AAP maintains a consistent internal lobbying team of four lobbyists, Ami Gadhia, Patrick Johnson, Stephanie Glier, and Namrata Pujara.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article